Persones / Equip Humà

Angel Montero Carcaboso

Buscador de publicacions

Publicacions

  • Cancela MB, Winter U, Zugbi S, Dinardi M, Alves da Quinta D, Aschero MR, Ganiewich D, Sampor C, Sgroi M, Lagomarsino E, Fandiño A, Llera AS, Chantada G, Carcaboso AM and Schaiquevich P.

    Mimicking Retinoblastoma Treatment With Repeated Topotecan or Melphalan Develops Cross-Resistance to Classic Agents But Not to Repurposed Drugs.

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 65(14): 14-14.

    [doi:10.1167/iovs.65.14.14]

  • Huchede P, Meyer S, Berthelot C, Hamadou M, Bertrand-Chapel A, Rakotomalala A, Manceau L, Tomine J, Lespinasse N, Lewandowski P, Cordier-Bussat M, Broutier L, Dutour A, Rochet I, Blay JY, Degletagne C, Attignon V, Carcaboso AM, Le Grand M, Pasquier E, Vasiljevic A, Gilardi-Hebenstreit P, Meignan S, Leblond P, Ribes V, Cosset E and Castets M.

    BMP2 and BMP7 cooperate with H3.3K27M to promote quiescence and invasiveness in pediatric diffuse midline gliomas.

    eLife . 12: .

    [doi:10.7554/eLife.91313]

  • Pascual-Pastó G, McIntyre B, Giudice AM, Alikarami F, Morrissey A, Matlaga S, Hofmann TJ, Burgeño-Sandoval V, Harvey K, Martinez D, Shah AC, Foster JB, Pogoriler J, Eagle RC, Carcaboso AM, Shields CL, Leahey AM and Bosse KR.

    Targeting GPC2 on Intraocular and CNS Metastatic Retinoblastomas with Local and Systemic Delivery of CAR T Cells

    CLINICAL CANCER RESEARCH . 30(16): 3578-3591.

    [doi:10.1158/1078-0432.CCR-24-0221]

  • Brown, Elizabeth J., Balaguer-Lluna, Leire, Cribbs, Adam P., Philpott, Martin, Campo, Leticia, Browne, Molly, Wong, Jong Fu, Oppermann, Udo, Carcaboso AM, Bullock, Alex N. and Farnie, Gillian.

    PRMT5 inhibition shows in vitro efficacy against H3K27M-altered diffuse midline glioma, but does not extend survival in vivo

    SCIENTIFIC REPORTS . 14(1): . Nº de cites: 2

    [doi:10.1038/s41598-023-48652-x]

  • Wiese M, Pohlmeier B, Kubiak K, El-Khouly FE, Sitte M, Carcaboso AM, Baugh JN, Perwein T, Nussbaumer G, Karremann M, Gielen GH, Salinas G and Kramm CM.

    Boswellic acid formulations are not suitable for treatment of pediatric high-grade glioma due to tumor promoting potential

    Journal of Traditional and Complementary Medicine . 14(1): 101-108.

    [doi:10.1016/j.jtcme.2023.07.007]

  • Aschero MR, Ganiewich D, Lamas G, Restrepo-Perdomo CA, Ottaviani D, Zugbi S, Camarero S, Néspoli E, Cuadrado-Vilanova M, Pérez-Jaume S, Pascual-Pastó G, Sampor C, Grigorovski N, Salas B, Suñol M, Carcaboso AM, Mora J, de Dávila MTG, Doz F, Radvanyi F, Abramson DH, Llera AS, Schaiquevich PS, Lubieniecki F and Chantada G.

    Immunohistochemical expression of TFF1 is a marker of poor prognosis in retinoblastoma

    PEDIATRIC BLOOD & CANCER . 71(1): . Nº de cites: 1

    [doi:10.1002/pbc.30717]

  • Zugbi S, Aschero R, Ganiewich D, Cancela MB, Winter U, Ottaviani D, Sampor C, Dinardi M, Torbidoni AV, Mena M, Balaguer-Lluna L, Lamas G, Sgroi M, Lagomarsino E, Lubieniecki F, Fandiño A, Radvanyi F, Abramson DH, Podhajcer O, Llera AS, Cafferata EG, Chantada G, Carcaboso AM and Schaiquevich P.

    Establishment and Comprehensive Characterization of a Novel Preclinical Platform of Metastatic Retinoblastoma for Therapeutic Developments

    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE . 64(15): 27-27. Nº de cites: 2

    [doi:10.1167/iovs.64.15.27]

  • Lee K, Yun S, Park J, Lee S, Carcaboso AM, Yi SJ and Kim K.

    Dimethyl alpha-ketoglutarate inhibits proliferation in diffuse intrinsic pontine glioma by reprogramming epigenetic and transcriptional networks

    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS . 677: 6-12. Nº de cites: 1

    [doi:10.1016/j.bbrc.2023.07.050]

  • Fanlo, L, Gomez-Gonzalez S, Rozalen, C, Perez-Nunez, I, Sangrador, I, Tomas-Daza, L, Gautier, EL, Usieto, S, Rebollo, E, Vilà-Ubach M, Carcaboso AM, Javierre, BM, Celia-Terrassa, T, Lavarino C, Marti, E and Le Dreau, G.

    Neural crest-related NXPH1/a-NRXN signaling opposes neuroblastoma malignancy by inhibiting organotropic metastasis

    Oncogene . 42(28): 2218-2233. Nº de cites: 2

    [doi:10.1038/s41388-023-02742-2]

  • Mensali, N, Köksal, H, Joaquina, S, Wernhoff, P, Casey, NP, Romecin, P, Panisello, C, Rodriguez, R, Vimeux, L, Juzeniene, A, Myhre, MR, Fåne, A, Ramírez, CC, Maggadottir, SM, Duru, AD, Georgoudaki, AM, Grad, I, Maturana, AD, Gaudernack, G, Kvalheim, G, Carcaboso AM, de Alava, E, Donnadieu, E, Bruland, OS, Menendez, P, Inderberg, EM and Wälchli, S.

    ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma

    NATURE COMMUNICATIONS . 14(1): . Nº de cites: 12

    [doi:10.1038/s41467-023-39097-x]